CD45 Tyrosine Phosphatase Regulation of Signaling

Agency: National Institute of Health (NIH)
Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type: Research Project (R01)
Project #: 5R01DK047121-04
Application #: 2146457
Study Section: Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)


NIH 2004 R01 DK	Inhibitory Receptors and Their Mode of Action Cambier, John C. / University of Colorado Denver	$232,892
NIH 2003 R01 DK	Inhibitory Receptors and Their Mode of Action Cambier, John C. / University of Colorado Denver	$224,115
NIH 2002 R01 DK	Inhibitory Receptors and Their Mode of Action Cambier, John C. / National Jewish Health	$220,406
NIH 2001 R01 DK	Inhibitory Receptors and Their Mode of Action Cambier, John C. / National Jewish Health	$213,988
NIH 2000 R01 DK	Inhibitory Receptors and Their Mode of Action Cambier, John C. / National Jewish Health	$210,996
NIH 1997 R01 DK	CD45 Tyrosine Phosphatase Regulation of Signaling Cambier, John C. / National Jewish Health
NIH 1996 R01 DK	CD45 Tyrosine Phosphatase Regulation of Signaling Cambier, John C. / National Jewish Health
NIH 1995 R01 DK	CD45 Tyrosine Phosphatase Regulation of Signaling Cambier, John C. / National Jewish Health
NIH 1994 R01 DK	CD45 Tyrosine Phosphatase Regulation of Signaling Cambier, John C. / National Jewish Health
NIH 1993 R01 DK	CD45 Tyrosine Phosphatase Regulation of Signaling Cambier, John C. / National Jewish Health

Marschner, Susanne; Hunig, Thomas; Cambier, John C et al. (2002) Ligation of human CD4 interferes with antigen-induced activation of primary T cells. Immunol Lett 82:131-9